Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10160943
United States Court of Appeals for the Ninth Circuit
United States v. Grant
No. 10160943 · Decided October 24, 2024
No. 10160943·Ninth Circuit · 2024·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
October 24, 2024
Citation
No. 10160943
Disposition
See opinion text.
Full Opinion
FILED
NOT FOR PUBLICATION
OCT 24 2024
UNITED STATES COURT OF APPEALS MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
UNITED STATES OF AMERICA, No. 23-2525
Plaintiff-Appellee, D.C. NO. 1:22-CR-00069-LEK-1
v.
MEMORANDUM*
WILLIAM GRANT,
Defendant-Appellant.
Appeal from the United States District Court
for the District of Hawaii
Leslie E. Kobayashi, District Judge, Presiding
Argued and Submitted October 9, 2024
Honolulu, Hawaii
Before: MURGUIA, Chief Judge, and GRABER and MENDOZA, Circuit Judges.
Defendant William Grant pleaded guilty to distributing fentanyl contained in
ten transdermal patches, being a felon in possession of a firearm, and being a felon
in possession of ammunition. He timely appeals his 72-month sentence. We
affirm.
*
This disposition is not appropriate for publication and is not precedent except as
provided by Ninth Circuit Rule 36-3.
1. We review de novo a district court’s interpretation of the Sentencing
Guidelines. United States v. Campbell, 937 F.3d 1254, 1256 (9th Cir. 2019). We
review factual findings made during sentencing, including a determination of the
quantity of drugs involved in an offense, for clear error. United States v. Gadson,
763 F.3d 1189, 1219 (9th Cir. 2014); see also United States v. Gonzalez, 528 F.3d
1207, 1214 (9th Cir. 2008).
Grant argues that only the dosage amount stated on the packaging can be
used to determine the weight of the fentanyl––that is, 0.1 grams––whereas the
court adopted the DEA’s calculation and the presentencing recommendation of
23.8 grams.1 Note A to the Drug Quantity Table explains that, “[u]nless otherwise
specified, the weight of a controlled substance set forth in the table refers to the
entire weight of any mixture or substance containing a detectable amount of the
controlled substance.” U.S. Sent’g Guidelines Manual (“U.S.S.G.”) § 2D1.1(c)
1
On October 2, 2024, Grant filed a Motion for Miscellaneous Relief,
asserting that the 23.8 grams may have been calculated incorrectly. But Grant did
not challenge the 23.8-gram figure at any time, in the district court or here, until
filing that motion. Therefore, Grant has forfeited this argument. See United States
v. Depue, 912 F.3d 1227, 1232–33 (9th Cir. 2019) (holding that waiver is an
intentional relinquishment of a known right, whereas forfeiture is the failure to
assert a right in a timely manner); Mendoza v. Block, 27 F.3d 1357, 1363 (9th Cir.
1994), as amended (May 31, 1994) (“Failure to raise an issue on appeal results in
waiver of that issue.”). Thus, we decline to consider the argument.
2
(Notes to Drug Quantity Table (A)). Because fentanyl is not “otherwise specified,”
this approach controls.
Grant argues that the court should have applied Amendment 488, which
states that, “[i]n the case of LSD on a carrier medium (e.g., a sheet of blotter
paper), do not use the weight of the LSD/carrier medium. Instead, treat each dose
of LSD on the carrier medium as equal to 0.4 milligrams of LSD for the purposes
of the Drug Quantity Table.” U.S.S.G. § 2D1.1(c) (Notes to Drug Quantity Table
(G)). But that provision applies only to LSD, not to fentanyl. See United States v.
Smith, 499 U.S. 160, 167 (1991) (“Where Congress explicitly enumerates certain
exceptions to a general prohibition, additional exceptions are not to be implied, in
the absence of evidence of a contrary legislative intent.” (quoting Andrus v. Glover
Constr. Co., 446 U.S. 608, 616–17 (1980))). Nor does Application Note 9 to
Sentencing Guidelines § 2D1.1 apply, because the weight of the controlled
substance is known.
2. We review a district court’s application of the Sentencing Guidelines for
abuse of discretion. United States v. Gasca-Ruiz, 852 F.3d 1167, 1169–70 (9th Cir.
2017) (en banc).
In 2023, the Sentencing Commission proposed an amendment providing that
a defendant with Grant’s criminal history would receive one criminal history point,
instead of two, for committing new crimes while on probation. U.S.S.G. § 4A1.1
3
(2023). Grant moved to continue his sentencing until after the amendment’s
proposed effective date. The district court declined to continue the sentencing even
though it had continued the sentencings of other defendants. The court noted
several distinguishing characteristics, including the nature and circumstances of the
offense, Grant’s role in the offense, his offer to sell an operable firearm with the
fentanyl, the 1546 rounds of ammunition found, and Grant’s prior convictions and
arrests. In view of those factors, the district court did not abuse its discretion in
declining to continue Grant’s sentencing until after the proposed effective date of
the amendment, or in declining to apply the proposed amendment.
3. We typically review procedural errors raised for the first time on appeal
for plain error. United States v. Burgum, 633 F.3d 810, 812 (9th Cir. 2011). But
when a defendant advocates for a shorter sentence, “thereby arguing, in effect, that
this shorter sentence would have proved ‘sufficient,’” “the defendant [has]
properly preserved the claim” that the sentence was unreasonable. Holguin-
Hernandez v. United States, 589 U.S. 169, 175 (2020). We conclude that Grant
preserved this claim. In this situation, we review the sentence for abuse of
discretion. Gall v. United States, 552 U.S. 38, 51 (2007).
The district court based its upward variance on several aggravating factors:
“the serious harm to our community caused by [Grant’s offense]”; Grant’s history
and characteristics; the context of the direct sale of fentanyl, including the
4
simultaneous sale and possession of a dangerous weapon and the presence of
ammunition; and Grant’s criminal history. Grant argues that the district court erred
by considering the first factor. We disagree.
“At sentencing[,] judges may consider a wide variety of information that
could not be considered at trial.” United States v. Messer, 785 F.2d 832, 834 (9th
Cir. 1986). The disputed information on which the district court relied here, that
fentanyl causes harm to the community, was neither “false or unreliable,” id., and
the district court properly considered this factor, see 18 U.S.C. § 3553(a)(2)(A)
(providing that the sentencing court shall consider “the need for the sentence
imposed . . . to reflect the seriousness of the offense”). And the court did not abuse
its discretion by considering the other aggravating factors under § 3553(a)(2)(A).
See also 18 U.S.C. § 3661 (providing that a sentencing court may receive and
consider all “information concerning the background, character, and conduct” of
the defendant “for the purpose of imposing an appropriate sentence”).
AFFIRMED.
5
Plain English Summary
FILED NOT FOR PUBLICATION OCT 24 2024 UNITED STATES COURT OF APPEALS MOLLY C.
Key Points
01FILED NOT FOR PUBLICATION OCT 24 2024 UNITED STATES COURT OF APPEALS MOLLY C.
02COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, No.
03Kobayashi, District Judge, Presiding Argued and Submitted October 9, 2024 Honolulu, Hawaii Before: MURGUIA, Chief Judge, and GRABER and MENDOZA, Circuit Judges.
04Defendant William Grant pleaded guilty to distributing fentanyl contained in ten transdermal patches, being a felon in possession of a firearm, and being a felon in possession of ammunition.
Frequently Asked Questions
FILED NOT FOR PUBLICATION OCT 24 2024 UNITED STATES COURT OF APPEALS MOLLY C.
FlawCheck shows no negative treatment for United States v. Grant in the current circuit citation data.
This case was decided on October 24, 2024.
Use the citation No. 10160943 and verify it against the official reporter before filing.